The samples were analyzed in MACSQuant flow cytometer (Miltenyi Biotec, San Diego, CA, USA), placing the CellROX green reagent signal in FL1. down-regulation of antimicrobial peptide expression and increase in pro-inflammatory responses. Keywords: LL-37, Vitamin D3, Pro-inflammatory response, Innate immunity, Ventilator induced lung injury == Intro == Mechanical ventilation (MV) is a lifesaving treatment intended for patients suffering from severe respiratory failure by alleviating the work of breathing and facilitating alveolar gas exchange (Slutsky & Ranieri, 2013). MV has, however , been associated with side effects including ventilator induced lung injury (VILI) coupled with injury on lung tissue, stress on epithelial and endothelial barriers, apoptosis, pro-inflammatory responses, increased oxidative stress and secondary infections like nosocomial bacterial pneumonia. This can be followed by sepsis or systemic inflammatory response syndrome and increased mortality (Baudouin, 2001; Uhlig, 2002; Syrkina et al., 2008). Success of treatment with MV requires limitation of VILI and associated side effects (Fan, Villar & Slutsky, 2013). This can be accomplished by either decreasing mechanical stress produced by MV or by increasing the endurance of lung tissues to such strain. Hence, it has become imperative to study the molecular mechanisms behind VILI in details to improve outcomes in patients treated with MV. Although poorly defined, down-regulation of innate immune responses has been proposed to prefer bacterial growth and development of ventilator associated pneumonia (VAP) in the lungs of patients during MV (Santos et al., 2005). Antimicrobial polypeptides (AMPs) constitute an important arm from the innate immune defense in the lungs and are expressed ubiquitously in epithelial cells, neutrophils and monocytes or macrophages (Laube et al., 2006). These cationic polypeptides are categorized into: (1) smaller processed peptides such as cathelicidins and defensins and (2) larger polypeptides like lactoferrin, lysozyme and secretory leukocyte peptidase inhibitor (SLPI) (Laube et al., 2006). LL-37 is the main cathelicidin antimicrobial peptide (CAMP) in humans, encoded by theCAMPgene (Drr, Sudheendra & Ramamoorthy, 2006). LL-37 is stored as a pro-form (pro-LL-37) in cells and is activated upon secretion to the mature type LL-37 by specific proteases (Srensen et al., 2001). LL-37 offers direct antimicrobial activity against multiple pathogens and continues to be demonstrated to exhibit pro- and anti-inflammatory responses, wound recovery and angiogenic properties (Cederlund, Gudmundsson & Agerberth, 2011). Inducers of AMPs like vitamin D3 (1, 25-dihydroxy vitamin D3 or 1, 25D3) and 4-phenyl butyric acid (PBA) have been shown to increaseCAMPgene expression via the vitamin D receptor (VDR) (Gombart, Borregaard & Koeffler, 2005; Kulkarni et al., 2015a; Kulkarni et al., 2015b). A recent clinical trial demonstrated that reduce vitamin D3 levels and cathelicidin expression was associated with higher mortality in critically ill patients usually receiving MV (Leaf et al., 2015). The effects of MV on respiratory cells can be modeledin vitroby applying defined cyclic mechanical stretch mimicking the frequency and stretch conditions during MV (Pugin et al., 2008; Wu et al., 2013). In this study, we demonstrate that cyclic mechanical stretch of human being bronchial epithelial cells VA10 and BCi down-regulates the expression of antimicrobial peptide cathelicidin. Treatment with AMP inducers vitamin D3 and/or PBA counteracted cyclic stretch Rabbit polyclonal to Cannabinoid R2 mediated down-regulation of cathelicidin expression in VA10 cells. We further demonstrate that cyclic stretching of VA10 cells activated a pro-inflammatory response by enhancing expression of pro-inflammatory cytokines and increasing oxidative stress. PAC-1 == Materials and Methods == == Cell culture, reagents and cyclic stretch == An E6/E7 viral oncogene immortalized human bronchial epithelial cell line VA10 was cultured as explained previously (Halldorsson et al., 2007). Briefly, the cells were managed in Bronchial/Tracheal Epithelial cell growth medium (Cell Applications, San Diego, CA, USA) with Penicillin-Streptomycin ((20 U/ml, 20 g/ml, respectively) (Life Technologies, Carlsbad, CA, USA)) at 37 C and 5% CO2. BCi. NS 1 . 1 (henceforth referred to as BCi) is a human being bronchial epithelial cell range was a kind gift from Dr . Matthew S. Walters, Weill Cornell Medical College, New York NY, USA (Walters et al., 2013) and was established by immortalization with retrovirus expressing human telomerase (hTERT). The BCi cells were cultured as explained PAC-1 above intended for VA10 cell line. The same amount of cells were seeded on each well in a 6 well collagen I coated Bioflex plates (Flexcell International Corporation, Burlington, CA, USA), and grown to approximately 80% confluence. These plates were then transferred to a PAC-1 base plate of the cell stretching gear Flexcell FX-5000TM Tension System (Flexcell International Corporation, Burlington, CA, USA) in a humidified incubator at 37 C and 5% CO2. The cells were subjected to cyclic mechanical stretch with the.